Intraoperative detection of sentinel lymph nodes using Patent Blue V in non-small cell lung cancer

Minerva Chirurgica

Volumn 63, Issue 1, 2008, Pages 29-36

  Bustos, M E F ^a   Camargo, J J P ^a   Geyer, G Resin ^b   Andrade, C Feijó ^c,d  

^a Santa Casa de Porto Alegre   (Brazil)

^b NONE   (Brazil)

^c Santo Antonio Children's Hospital   (Brazil)

^d HOSPITAL DA CRIANÇA SANTO ANTÔNIO   (Brazil)

Author keywords

Carcinoma, non small cell lung; Coloring agents; Mediastinum; Sentinel lymph node biopsy

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; EVALUATION; FEASIBILITY STUDY; FEMALE; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; MEDIASTINUM; METASTASIS; MIDDLE AGED; PATHOLOGY; PATIENT SELECTION; PEROPERATIVE CARE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COLORING AGENTS; FEASIBILITY STUDIES; FEMALE; HUMANS; INTRAOPERATIVE CARE; LUNG; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 40749111438     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
2. Câncer INd. Estimativa de Câncer 2006 [Internet]. Rio de Janeiro: Instituto Nacional de Câncer-INCA. Publicações 2006. Available from: www.inca.gov.br/ estimativa/2006.
3. Birim O, Kappetein AP, van Klaveren RJ, Bogers AJ: Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 2006;32:12-23.
4. Birim O, Kappetein AP, Waleboer M, Puvimanasinghe JP, Eijkemans MJ, Steyerberg EW et al. Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode. J Thorac Cardiovasc Surg 2006;132:491-8.
5. Chen SL, Iddings DM, Scheri RP, Bilchik AJ. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin 2006;56:292-309.
6. Morton DL, Wen DR, Cochran AJ. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: a alternative to routine elective lymphadenectomy or watch and wait. Surg Oncol Clin North Am 1992;1: 247-59.
7. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
8. Ishizaki M, Kurita A, Kubo Y, Takashima S, Nishina T, Nishimura E et al. Evaluation of sentinel node identification with isosulfan blue in gastric cancer. Eur J Surg Oncol 2006;32:191-6.
9. Dahl K, Westlin J, Kraaz W, Winqvist O, Bergkvist L, Thörn M et al. Identification of sentinel nodes in patients with colon cancer. Eur J Surg Oncol 2005;31:381-5.
10. Tanis PJ, Nieweg OE, Valdés Olmos RA, Th Rutgers EJ, Kroon BB. History of sentinel node and validation of the technique. Breast Cancer Res 2001;3:109-12.
11. Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H et al. Lymph node sampling in lung cancer: how should it be done? Eur J Cardiothorac Surg 1999;16(Suppl 1):S17-24.
12. Rzyman W, Hagen OM, Dziadziuszko R, Kobierska-Gulida G, Karmolinski A, Lothe MI et al. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer. Eur J Surg Oncol 2006;32:462-5.
13. Little AG, DeHoyos A, Kirgan DM, Arcomano TR, Murray KD. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg 1999;117:220-4.
14. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-23.
15. Travis W, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumours. In WHO International Histological Classifications of Tumours. 3rd ed. New York: Springer; 1999.
16. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-9.
17. Passlick B: Mediastinal staging (take home messages). Lung Cancer 2004;45(Suppl 2):S85-7.
18. Fritscher-Ravens A, Bohuslavizki KH, Brandt L, Bobrowski C, Lund C, Knöfel WT et al. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest 2003;123:442-51.
19. Liptay MJ, Masters GA, Winchester DJ, Edelman BL, Garrido BJ, Hirschtritt TR et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 2000;70:384-9.
20. Mandel JWS. Overview of non-small cell lung cancer staging. Up To Date 2003.
21. Cerfolio RJ, Bryant AS. Distribution and likelihood of lymph node metastasis based on the lobar location of nonsmall-cell lung cancer. Ann Thorac Surg 2006;81: 1969-73.
22. Minamiya Y, Ogawa J. The current status of sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2005;11:67-72.
23. Sugi K, Fukuda M, Nakamura H, Kaneda Y. Comparison of three tracers for detecting sentinel lymph nodes in patients with clinical N0 lung cancer. Lung Cancer 2003;39:37-40.
24. Schmidt FE, Woltering EA, Webb WR, Garcia OM, Cohen JE, Rozans MH. Sentinel nodal assessment in patients with carcinoma of the lung. Ann Thorac Surg 2002;74:870-4; discussion 874-5.